Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus

Basit Öğe Kaydı
dc.authorid0000-0001-7306-5233en_US
dc.authorid0000-0003-2811-0052en_US
dc.authorid0000-0003-3085-7964en_US
dc.authorid0000-0003-4201-9757
dc.authorid0000-0002-4162-5563
dc.contributor.authorAktaş, Gülali
dc.contributor.authorKoçak, Mehmet Zahid
dc.contributor.authorBilgin, Satılmış
dc.contributor.authorAtak, Burçin Meryem
dc.contributor.authorDuman, Tuba Taslamacıoğlu
dc.contributor.authorKurtkulağı, Özge
dc.date.accessioned2021-06-23T19:17:12Z
dc.date.available2021-06-23T19:17:12Z
dc.date.issued2019
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractAim: Despite it has some disadvantages, the most important marker of diabetic control is glycated hemoglobin (HbA1c). Uric acid to HDL cholesterol ratio (UHR) is a promising marker in metabolic syndrome. We aimed to compare UHR levels of well and poorly controlled type 2 diabetic male subjects, as well as healthy men, and to observe its correlation with other metabolic parameters. Methods: Male patients with T2DM that showed up in outpatient internal medicine clinics of our hospital were enrolled to the study. Diabetic subjects divided into two groups according to the level of HbA1c: well-controlled T2DM group (HbA1c?<?7%) and poorly controlled T2DM group (HbA1c???7%). Third group was consisted of healthy subjects without any chronic diseases. UHR levels of the groups were compared. Results: The UHR levels of well and poorly controlled diabetics and control subjects were 12%?5%, 17%?6% and 9%?3%, respectively (p<.001). The UHR was significantly and inversely correlated with GFR and was significantly and positively correlated with waist circumference, body weight, body mass index, serum creatinine, fasting plasma glucose (FPG) and HbA1c levels. Conclusion: UHR could serve as a promising predictor of diabetic control in men with T2DM, since it has significant association with HbA1c and FPG levels.en_US
dc.identifier.doi10.1080/13685538.2019.1678126
dc.identifier.endpage1102
dc.identifier.issn1368-5538
dc.identifier.issue5
dc.identifier.pmid31615320en_US
dc.identifier.scopus2-s2.0-85074375334en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1098
dc.identifier.urihttps://doi.org/10.1080/13685538.2019.1678126
dc.identifier.urihttps://hdl.handle.net/20.500.12491/5286
dc.identifier.volume23
dc.identifier.wosWOS:000490688000001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorAktaş, Gülali
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofAging Maleen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectUric Acid to HDL Cholesterol Ratioen_US
dc.subjectType 2 Diabetes Mellitusen_US
dc.subjectHbA1cen_US
dc.subjectFasting Plasma Glucoseen_US
dc.titleUric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitusen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
gulali-aktas2.pdf
Boyut:
1.05 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/ Full text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu